Highlights and Quick Summary
- Long-term assets (Other) for the quarter ending September 30, 2022 was $3.15 Million (a -9.95% decrease compared to previous quarter)
- Year-over-year quarterly Long-term assets (Other) decreased by -13.25%
- Annual Long-term assets (Other) for 2021 was $3.63 Million (a 16.68% increase from previous year)
- Annual Long-term assets (Other) for 2020 was $3.11 Million (a 2.81% increase from previous year)
- Annual Long-term assets (Other) for 2019 was $3.03 Million (a 857.59% increase from previous year)
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Long-term assets (Other) of Atreca, Inc.
Most recent Long-term assets (Other)of BCEL including historical data for past 10 years.Interactive Chart of Long-term assets (Other) of Atreca, Inc.
Atreca, Inc. Long-term assets (Other) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $3.15 | $3.5 | $3.54 | – |
| 2021 | $3.63 | $3.08 | $2.85 | $3.08 | $3.63 |
| 2020 | $3.11 | $3.04 | $2.93 | $2.9 | $3.11 |
| 2019 | – | $3.03 | $1.51 | $0.97 | $3.03 |
| 2018 | – | – | – | $0.32 | $0.32 |
| 2017 | – | – | – | – | $0.34 |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology